Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.04.18	Allergan Announces Second Positive Phase 3 Clinical Trial for Ubrogepant -- an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine (PR Newswire)
26.04.18	Allergan Presents Data at the Annual Meeting of the Association of Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu (PR Newswire)
20.04.18	Takeda Raises Offer For Shire To GBP 47.00/shr (RTTNews)
20.04.18	Allergan Showcases Leadership in Neurosciences with 25 Presentations at the American Academy of Neurology Annual Meeting in Los Angeles (PR Newswire)
19.04.18	Allergan Does Not Intend to Make an Offer for Shire plc; Strategic Review Continues (PR Newswire)
19.04.18	Allergan Says It In Early Stages Of Considering Possible Offer For Shire (RTTNews)
19.04.18	Allergan Issues Statement Regarding Press Speculation on its Strategic Review (PR Newswire)
13.04.18	Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting (PR Newswire)
10.04.18	Genpact Schedules Earnings Release and Conference Call for First Quarter 2018 Results (PR Newswire)
06.04.18	Allergan Presents Results From Global Survey Highlighting the Importance of Trust in Medical Aesthetics (PR Newswire)
03.04.18	Allergan, Richter Report Positive Topline Results From Third Cariprazine Trial (RTTNews)
03.04.18	Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression (PR Newswire)
03.04.18	Allergan Reportedly Considers Options For Its Women's Health Unit (RTTNews)
02.04.18	Allergan Receives 2018 ENERGY STAR® Partner of the Year - Sustained Excellence Award (PR Newswire)
02.04.18	Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast (PR Newswire)
23.03.18	Amgen, Allergan: CHMP Adopts Positive Opinion For ABP 980 - Quick Facts (RTTNews)
23.03.18	Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin®) For The Treatment Of Three Types Of Cancer (PR Newswire)
22.03.18	Ozurdex® (dexamethasone 0.7mg) now available for millions of patients in China with macular edema secondary to retinal vein occlusion (PR Newswire)
22.03.18	Ozurdex(R) (dexamethasone 0.7mg) now available for millions of patients in China with macular edema secondary to retinal vein occlusion (PR Newswire)
15.03.18	New Score to Find Out if Influencers Are #Influential (PR Newswire)
14.03.18	Allergan CEO Brent Saunders Receives $32.83 Mln Compensation In 2017 (RTTNews)
06.03.18	CoolSculpting® Takes to the Ice with Iconic Figure Skater Johnny Weir to Debunk Fat Loss Myths (PR Newswire)
01.03.18	Groundbreaking ZingBox Report Analyzes Connected Medical Devices Across 50 Locations, Shedding Light on IoT Security Vulnerabilities (PR Newswire)
28.02.18	Mylan, Revance Announce License Agreement For Proposed Biosimilar To BOTOX (RTTNews)
28.02.18	Allergan Announces FDA Has Extended The Ulipristal Acetate NDA Review Period To August 2018 (PR Newswire)
28.02.18	Allergan to Present at The Barclays Global Healthcare Conference (PR Newswire)
26.02.18	Allergan to Present at The Cowen and Company 38th Annual Health Care Conference (PR Newswire)
26.02.18	MediaSilo and Wiredrive Launch SHIFT: Where Creative Work Flows (PR Newswire)
26.02.18	Mylan: PTAB Denies Tribe's Motion To Terminate Patent Challenge On Restasis (RTTNews)
17.02.18	Allergan Presents Data at the 2018 American Academy of Dermatology (AAD) Annual Meeting in San Diego (PR Newswire)
09.02.18	Allergan Declares First Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share and Provides Annual General Meeting of Shareholders Updates (PR Newswire)
08.02.18	Mediant Celebrates Milestone Year with Plans to Continue Momentous Growth into 2018 (PR Newswire)
06.02.18	Allergan Inc. Profit Advances In Q4 (RTTNews)
06.02.18	Allergan Says ACHIEVE 1 Phase 3 Study For Ubrogepant Meets Co-primary Endpoints (RTTNews)
06.02.18	Allergan Reports Solid Finish to 2017 with 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3 Billion (PR Newswire)
06.02.18	Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine (PR Newswire)
05.02.18	Allergan Names Matthew Walsh EVP & CFO - Quick Facts (RTTNews)
05.02.18	Matthew M. Walsh Appointed Executive Vice President and Chief Financial Officer of Allergan plc (PR Newswire)
02.02.18	AGN's Superbug Antibiotic Gets FDA Nod, AFMD Soars, Boxed Warning For Ocaliva (RTTNews)
01.02.18	FDA Approves AVYCAZ® (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia (PR Newswire)
31.01.18	Allergan to Present at The Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
31.01.18	Allergan Introduces "Not Cool vs. Cool" Multi-Channel Campaign for CoolSculpting® and Professional Athlete Brand Ambassadors: Figure Skater Johnny Weir and Golfer Ian Poulter (PR Newswire)
25.01.18	Banco Internacional del Perú S.A.A. announces the early settlement results for its offer to exchange up to US$500 million of its Panamanian branch's outstanding 5.750% Senior Notes due 2020 for... (PR Newswire)
19.01.18	Amgen And Allergan's MVASI Gets EU Approval To Treat Certain Types Of Cancer (RTTNews)
18.01.18	European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer (PR Newswire)
16.01.18	The Race To Find A Treatment For NASH (RTTNews)
08.01.18	Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference (PR Newswire)
08.01.18	Allergan to Report Fourth Quarter and Full Year 2017 Earnings and Host Conference Call and Webcast (PR Newswire)
30.12.17	Pershing Square, Valeant Agree To Pay $290 Mln To Settle Allergan Lawsuit (RTTNews)
21.12.17	Allergan: FDA Accepts NDA For Acne Drug Seysara (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Allergan plc

Aktien Top/Flop

Allergan Peer Group Nachrichten

Meistgelesene Nachrichten